IL1B and chronic myelogenous leukemia, BCR-ABL1 positive: In the pathogenesis of CML, pro-inflammatory cytokines, including IL-6, IL-1β, and TNF-α, are upregulated in the serum [103], and this “pro-inflammatory environment” may promote a selective advantage for LSCs.